SCHEMBL5669268

SCHEMBL5669268

OC(CNC1(Cc2cccc(C(F)(F)C(F)(F)F)c2)CCCC(Oc2ccccc2)C1)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CETP P11597 19/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5669750 0.89 CETP (0.32) CETP
SCHEMBL6276333 0.88 CETP (0.48) CETP
SCHEMBL5670850 0.87 CETP (0.33) CETP
SCHEMBL5670064 0.86 CETP (0.51) CETP
SCHEMBL7790102 0.86 CETP (0.49) CETP
SCHEMBL5669307 0.84 CETP (0.35) CETP
SCHEMBL5669973 0.80 SMYD3 (0.36) CETP
SCHEMBL5669580 0.78 CETP (0.34) CETP
SCHEMBL5669779 0.78 CETP (0.42) CETP
SCHEMBL6567535 0.78 HTT (0.37) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670446-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2006-06-21 EP claimed
WO-2005030185-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2005-04-07 WO claimed
EP-1469831-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS Pfizer Products Inc. (US) 2004-10-27 EP disclosed
WO-2003063832-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS PFIZER PRODUCTS INC. (US) 2003-08-07 WO disclosed